Non-Paxlovid Rebound; Pandemic Spike in Early Puberty; New Therapy for Nightmares?

(MedPage Today) -- Note that some links may require subscriptions.
Outpatient COVID treatment with nirmatrelvir-ritonavir (Paxlovid) was 36% and 30% lower for Black and Hispanic patients compared with white patients, a CDC report found.
A high...

Source: MedPage Today Psychiatry - October 28, 2022 Category: Psychiatry Source Type: news